A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
New findings help increase understanding of molecular mechanisms for common forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Incorporating topotecan into front-line therapy of advanced localized retinoblastoma cures patients and improves survival of eyes with useful vision.
Researchers identify the molecular events that activate inflammasomes to initiate the innate immune response against bacterial invaders.
Newly identified type of lung macrophage protects chemotherapy-treated mice from lethal bacterial pneumonia despite absence of neutrophils.
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
St. Jude and Methodist Healthcare sign agreement to advance center for adult sickle cell disease in Memphis
The newly expanded Methodist Comprehensive Sickle Cell Center will strengthen research into sickle cell disease and serve the growing needs of patients in the Memphis area.
Explore more research news
More Research News
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Twitter
Connect with @stjuderesearch to keep up with our latest science and medical discoveries.
Browse all scientific publications by St. Jude investigators in 2015.